Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Over the decades, we have established ourselves as a leading player in the discovery of new molecules both NCEs (New Chemical Entity) and NBEs (New Biological Entity). They have several molecules in various stages of pre-clinical and clinical development and are primarily focused in the areas of Oncology, Respiratory and Dermatology.
Bouwer Bartlett operates as a drug sales and marketing company.
Servycal
Acquisition in 2005
Servycal is a company that specializes in providing quality control and development services specifically for the pharmaceutical industry. It focuses on the oncology sector, offering a range of products related to cancer therapy. Servycal's expertise includes cytotoxics, anti-hormonal treatments, and supportive therapies, catering to the needs of healthcare providers and patients in the fight against cancer. Through its commitment to quality and innovation, Servycal plays a vital role in enhancing the efficacy and safety of cancer treatments.
Laboratorios Klinger
Acquisition in 2004
Laboratorios Klinger operates as a generic and OTC drug marketer.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.